These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 24119647)

  • 1. Functional potentials of human hematopoietic progenitor cells are maintained by mesenchymal stromal cells and not impaired by plerixafor.
    Ludwig A; Saffrich R; Eckstein V; Bruckner T; Wagner W; Ho AD; Wuchter P
    Cytotherapy; 2014 Jan; 16(1):111-21. PubMed ID: 24119647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plerixafor induces the rapid and transient release of stromal cell-derived factor-1 alpha from human mesenchymal stromal cells and influences the migration behavior of human hematopoietic progenitor cells.
    Wuchter P; Leinweber C; Saffrich R; Hanke M; Eckstein V; Ho AD; Grunze M; Rosenhahn A
    Cell Tissue Res; 2014 Feb; 355(2):315-26. PubMed ID: 24337688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AMD3100 and CD26 modulate mobilization, engraftment, and survival of hematopoietic stem and progenitor cells mediated by the SDF-1/CXCL12-CXCR4 axis.
    Broxmeyer HE; Hangoc G; Cooper S; Campbell T; Ito S; Mantel C
    Ann N Y Acad Sci; 2007 Jun; 1106():1-19. PubMed ID: 17360804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of stromal-derived factor-1 in the hematopoietic-supporting activity of human mesenchymal stem cells.
    Van Overstraeten-Schlögel N; Beguin Y; Gothot A
    Eur J Haematol; 2006 Jun; 76(6):488-93. PubMed ID: 16494621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of a dual-injection regimen, plerixafor and CXCR4 on in utero hematopoietic stem cell transplantation and engraftment with use of the sheep model.
    Goodrich AD; Varain NM; Jeanblanc CM; Colon DM; Kim J; Zanjani ED; Hematti P
    Cytotherapy; 2014 Sep; 16(9):1280-93. PubMed ID: 25108653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of circulating CD34(+) cells with SDF-1alpha or anti-CXCR4 antibody enhances migration and NOD/SCID repopulating potential.
    Plett PA; Frankovitz SM; Wolber FM; Abonour R; Orschell-Traycoff CM
    Exp Hematol; 2002 Sep; 30(9):1061-9. PubMed ID: 12225798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microcavity arrays as an in vitro model system of the bone marrow niche for hematopoietic stem cells.
    Wuchter P; Saffrich R; Giselbrecht S; Nies C; Lorig H; Kolb S; Ho AD; Gottwald E
    Cell Tissue Res; 2016 Jun; 364(3):573-584. PubMed ID: 26829941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemokine stromal cell-derived factor-1alpha modulates VLA-4 integrin-dependent adhesion to fibronectin and VCAM-1 on bone marrow hematopoietic progenitor cells.
    Hidalgo A; Sanz-Rodríguez F; Rodríguez-Fernández JL; Albella B; Blaya C; Wright N; Cabañas C; Prósper F; Gutierrez-Ramos JC; Teixidó J
    Exp Hematol; 2001 Mar; 29(3):345-55. PubMed ID: 11274763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CXCR4 Antagonist AMD3100 Promotes Mesenchymal Stem Cell Mobilization in Rats Preconditioned with the Hypoxia-Mimicking Agent Cobalt Chloride.
    Liu L; Yu Q; Fu S; Wang B; Hu K; Wang L; Hu Y; Xu Y; Yu X; Huang H
    Stem Cells Dev; 2018 Apr; 27(7):466-478. PubMed ID: 29433375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined effects of hematopoietic progenitor cell mobilization from bone marrow by granulocyte colony stimulating factor and AMD3100 and chemotaxis into the brain using stromal cell-derived factor-1α in an Alzheimer's disease mouse model.
    Shin JW; Lee JK; Lee JE; Min WK; Schuchman EH; Jin HK; Bae JS
    Stem Cells; 2011 Jul; 29(7):1075-89. PubMed ID: 21608078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist.
    Broxmeyer HE; Orschell CM; Clapp DW; Hangoc G; Cooper S; Plett PA; Liles WC; Li X; Graham-Evans B; Campbell TB; Calandra G; Bridger G; Dale DC; Srour EF
    J Exp Med; 2005 Apr; 201(8):1307-18. PubMed ID: 15837815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The sphingosine 1-phosphate receptor agonist FTY720 supports CXCR4-dependent migration and bone marrow homing of human CD34+ progenitor cells.
    Kimura T; Boehmler AM; Seitz G; Kuçi S; Wiesner T; Brinkmann V; Kanz L; Möhle R
    Blood; 2004 Jun; 103(12):4478-86. PubMed ID: 14988150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stromal cell-derived factor-1 mediates changes of bone marrow stem cells during the bone repair process.
    Okada K; Kawao N; Yano M; Tamura Y; Kurashimo S; Okumoto K; Kojima K; Kaji H
    Am J Physiol Endocrinol Metab; 2016 Jan; 310(1):E15-23. PubMed ID: 26530150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances on the use of the CXCR4 antagonist plerixafor (AMD3100, Mozobil™) and potential of other CXCR4 antagonists as stem cell mobilizers.
    De Clercq E
    Pharmacol Ther; 2010 Dec; 128(3):509-18. PubMed ID: 20826182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TGFBI Expressed by Bone Marrow Niche Cells and Hematopoietic Stem and Progenitor Cells Regulates Hematopoiesis.
    Klamer SE; Dorland YL; Kleijer M; Geerts D; Lento WE; van der Schoot CE; von Lindern M; Voermans C
    Stem Cells Dev; 2018 Nov; 27(21):1494-1506. PubMed ID: 30084753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesenchymal stem cells feeder layer from human umbilical cord blood for ex vivo expanded growth and proliferation of hematopoietic progenitor cells.
    Jang YK; Jung DH; Jung MH; Kim DH; Yoo KH; Sung KW; Koo HH; Oh W; Yang YS; Yang SE
    Ann Hematol; 2006 Apr; 85(4):212-25. PubMed ID: 16391912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocyte growth factor/scatter factor (HGF/SF) is produced by human bone marrow stromal cells and promotes proliferation, adhesion and survival of human hematopoietic progenitor cells (CD34+).
    Weimar IS; Miranda N; Muller EJ; Hekman A; Kerst JM; de Gast GC; Gerritsen WR
    Exp Hematol; 1998 Aug; 26(9):885-94. PubMed ID: 9694510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trafficking mechanism of bone marrow-derived mesenchymal stem cells toward hepatocellular carcinoma HepG2 cells by modulating Endoglin, CXCR4 and TGF-β.
    Mardomi A; Sabzichi M; Hussein Somi M; Shanehbandi D; Rahbarghazi R; Taj Sanjarani O; Samadi N
    Cell Mol Biol (Noisy-le-grand); 2016 Sep; 62(11):81-86. PubMed ID: 27755957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CXCR4 antagonist delivery on decellularized skin scaffold facilitates impaired wound healing in diabetic mice by increasing expression of SDF-1 and enhancing migration of CXCR4-positive cells.
    Liu H; Liu H; Deng X; Chen M; Han X; Yan W; Wang N
    Wound Repair Regen; 2017 Aug; 25(4):652-664. PubMed ID: 28783870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Junctional Adhesion Molecule-A Is Highly Expressed on Human Hematopoietic Repopulating Cells and Associates with the Key Hematopoietic Chemokine Receptor CXCR4.
    Chang CH; Hale SJ; Cox CV; Blair A; Kronsteiner B; Grabowska R; Zhang Y; Cook D; Khoo CP; Schrader JB; Kabuga SB; Martin-Rendon E; Watt SM
    Stem Cells; 2016 Jun; 34(6):1664-78. PubMed ID: 26866290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.